31 — 6 (44) 2022 — Rakhmanov Kh.A., Islamov Sh.E., Makhmudjonova S.R., MORPHOLOGICAL CHARACTERISTICS OF PROSTATE CANCER

MORPHOLOGICAL CHARACTERISTICS OF PROSTATE CANCER

Rakhmanov Kh.A., Samarkand State Medical University

Islamov Sh.E., Samarkand State Medical University

Makhmudjonova S.R., Samarkand State Medical University

Resume

The article is devoted to the morphological characteristics of prostate cancer. It was found that the morphological diagnosis of prostate cancer is difficult, since the signs of malignancy can be barely noticeable, which increases the likelihood of a false negative result. However, there are many benign processes that mimic a malignant tumor, which can lead to misdiagnosis. In recent years, the use of immunohistological markers has been recommended, which can be used to determine their level, which increases with prostate cancer

Key words: prostate cancer, morphology, characteristics

First page

178

Last page

181

For citation: Rakhmanov Kh.A., Islamov Sh.E., Makhmudjonova S.R., MORPHOLOGICAL CHARACTERISTICS OF PROSTATE CANCER //New Day in Medicine 6(44)2022 178-181 https://clck.bar/L14e31

LIST OF REFERENCES:

1. Bhojani N., Salomon L., Capitanio U., et al. External validation of the updated Partin tables in a cohort of French and Italian men. // Int. J. Radiat. Oncol. Biol. Phys. 2009. Vol.73 – P.347-52.
2. Derweesh I.H., Kupelian P.A. Continuing trends in pathological stage migration in radical prostatectomy specimens. //Urol. Oncol. – 2004. – Jul-Aug; 22(4): – P. 300-6.
3. Eckersberger E., Finkelstein J., Sadri H., Margreiter M., Djavan B. et al Screening for Prostate Cancer: A Review of the ERSPC and PLCO Trials. //Reviews in Urology. – Vol. 11 № 3. – 2009. – Р. 127-133
4. Eble J.N. et al.: Pathology and Genetics: Tumors of the urinary system and male genital organs. WHO classification of tumors. //World Health Organization, Geneva, – 2004. – 299 p.
5. Epstein J.I., Netto G.J. Biopsy Interpretation of the Prostate. Philadelphia, JB Lippincott Williams & Wilkins, 2008. ISBN9781469887517-  440 p.
6. Gretzer M.B., Partin A.W. PSA markers in prostate cancer detection. //Urol. Clin. North. Am. – 30, 2003. –  30 (4): – P. 677-86.  doi: 10.1016/s0094-0143(03)00057-0.
7. Islamov Sh.E. Subjectivity in defects in rendering medical aid // European science review, Vienna, 2018. – №11-12. – P. 95-97.
8. Messing E.M., Manola J., Sarosdy M. et al. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer // N.Engl.J.Med. — 1999. — V. 341, № 9.— Р. 1781—1788.
9. Prayer-Galetti T., Zattoni F., Capizzi A. et al. Disease free survival in patients with pathological C stage prostate cancer at radical reropubic prostatectomy submitted to adjuvant hormonal treatment // Eur.Urol. — 2000. — V. 38. — Аbstr. 504.
10. Van de Kwast T. et al Single Prostatic Cancer Foci on Prostate Biopsy. // Eur Urol supp 7. 2008. – Р. 549-556.